VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 134 filers reported holding VIKING THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $298,115 | -31.3% | 26,930 | +3.3% | 0.00% | -50.0% |
| Q1 2023 | $433,949 | +1012.7% | 26,063 | +81.2% | 0.00% | – |
| Q3 2022 | $39,000 | -9.3% | 14,382 | -2.6% | 0.00% | – |
| Q2 2022 | $43,000 | -20.4% | 14,763 | -17.2% | 0.00% | – |
| Q1 2022 | $54,000 | -82.7% | 17,840 | -73.8% | 0.00% | -100.0% |
| Q4 2021 | $313,000 | +63.9% | 68,119 | +124.0% | 0.00% | 0.0% |
| Q3 2021 | $191,000 | -67.8% | 30,415 | -69.3% | 0.00% | -50.0% |
| Q2 2021 | $594,000 | -11.6% | 99,166 | -6.7% | 0.00% | -50.0% |
| Q1 2021 | $672,000 | +168.8% | 106,255 | +139.6% | 0.00% | +100.0% |
| Q4 2020 | $250,000 | -56.9% | 44,348 | -55.5% | 0.00% | -75.0% |
| Q3 2020 | $580,000 | -34.5% | 99,684 | -9.7% | 0.01% | +60.0% |
| Q4 2019 | $885,000 | +59.7% | 110,347 | +37.1% | 0.01% | 0.0% |
| Q3 2019 | $554,000 | -50.8% | 80,479 | -40.7% | 0.01% | -54.5% |
| Q2 2019 | $1,126,000 | +123.9% | 135,718 | +168.2% | 0.01% | +120.0% |
| Q1 2019 | $503,000 | -13.4% | 50,600 | -33.4% | 0.01% | -28.6% |
| Q4 2018 | $581,000 | – | 75,943 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |